Activity Description
In this video Jacob Lang, OD and Cecelia Koetting, OD explores innovative treatments for Demodex blepharitis and MGD, highlighting real-world outcomes and emphasizing early intervention, personalized care, and patient adherence to improve eyelid margin health and maintain long-term therapeutic success.
Accreditation
Sponsored by
The Fundingsland Group, LLC is a COPE-Approved Administrator.
This activity, COPE Activity Number 129972, is accredited by COPE for continuing education for optometrists. This course is approved for .25 hours of CE.
Course # 95700-TD
Activity #: 129972
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
Release Date: 01-27-2025
Expiration Date: 01-27-2026
Grant Support Statement
This activity is supported by unrestricted educational grants from Johnson & Johnson Vision, Sight Sciences, and Tarsus Pharmaceuticals, Inc.
Faculty
Jacob Lang, OD, FAAO
Cecelia Koetting, OD, FAAO